19-05-22-EuroPCR2019-main-live-11-42-17_

AWARD FOR INNOVATION IN CARDIOLOGY

Recognizing Groundbreaking Contributions in the Field

The Jon DeHaan Foundation provides funding to individuals and companies who focus on commercializing innovative developments in cardiovascular medicine.

 
 

MAKING A DIFFERENCE

Award Recipients

 
621.jpg

TCT 2022

Puzzle Medical Devices, Inc.

“It is an honor to be recognized by CRF and the Jon DeHaan Foundation. Our team is grateful to have been chosen from the other innovative companies that presented at this year’s TCT Shark Tank Innovation Competition. With the successful completion of our first in-human study, further investigations are underway using the ModulHeart device."

Jade Doucet-Martineau

Co-founder and CEO

THE DEHAAN CENTER FOR MEDICAL INNOVATION

Technology - Research - Education

Miedema Headshot.jpg

Jon DeHaan is pleased to personally award Dr. Michael Miedema's research into the prognostic significance and clinical utility of coronary artery calcium (CAC) for risk assessment for atherosclerotic cardiovascular disease (ASCVD) in younger adults.

Dr. Michael Miedema is the director of cardiovascular prevention at the Minneapolis Heart Institute and the medical director of the Nolan Family Center for Cardiovascular Health at the Minneapolis Heart Institute Foundation. He attended medical school at the University of Minnesota, completed internal medicine residency at Abbott Northwestern Hospital in Minneapolis, and then returned to the University of Minnesota to complete his cardiovascular fellowship. He completed his training in Boston, Massachusetts with a cardiovascular prevention fellowship at Brigham and Women’s Hospital as well as obtaining a master’s in public health from Harvard University School of Public Health. He started his position with the Minneapolis Heart Institute in 2013 and is focusing his research on determining the optimal individual and population based approaches for the prevention of cardiovascular disease. Dr. Miedema was a member of the executive review committee for the 2018 ACC/AHA cholesterol guidelines, was a committee member for the 2019 ACC/AHA guidelines for the primary prevention of cardiovascular disease, and is a current member of the American Heart Association Diabetes Council.

Says Dr. Miedema, "I am very honored to receive this award from the Jon DeHaan Center for Medical Innovation. At the Nolan Family Center for Cardiovascular Health at the Minneapolis Heart Institute Foundation, we are trying to improve cardiovascular health through research, education, and leadership and this award provides validation of those efforts. It is greatly appreciated."

Read Dr. Miedema's publication, "Coronary Artery Calcium for Risk Assessment in Young Adults" here.

 

CONTACT JON DEHAAN FOUNDATION

Thanks for submitting!